Follow
Maha Almackenzie
Maha Almackenzie
Rheumatologist
Verified email at sfh.med.sa
Title
Cited by
Cited by
Year
Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases
V Nagaraja, C Mara, PP Khanna, R Namas, A Young, DA Fox, T Laing, ...
Quality of Life Research 27 (3), 755-764, 2018
562018
Successful treatment of central nervous system vasculitis associated with relapsing polychondritis with cyclophosphamide
M Almackenzie, A Alharbi, S Alhassan, E Cook, N Altorok
The American Journal of the Medical Sciences 353 (5), 495-497, 2017
72017
Renal injury in scleromyxoedema due to monoclonal gammopathy associated C3 glomerulonephritis
S Kao, SDS Krupnikova, M AlMackenzie, G Atefi
BMJ Case Reports CP 15 (11), e250296, 2022
2022
Anti HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies; A Case Series
M Almackenzie, lisa Rider, R Curiel
4th Global Conference on Myositis, 2022
2022
COVID catalyst: telemedicine in rheumatology protects patient care beyond just the pandemic
A Kilian, M Chand, M Almackenzie, N Mbuy, S Bilal, G Atef, ...
International Journal of Clinical Rheumatology, 2021
2021
Establishing Clinical Severity for Patient Reported Outcomes Measurement Information System Measures in Adult Patients with Rheumatic Diseases
V Nagaraja, C Mara, CV Dodge, D Fox, P Khanna, T Laing, WJ McCune, ...
ARTHRITIS & RHEUMATOLOGY 68, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–6